Anticoagulation Desktop Reference

Anticoagulation Toolkit (Version ). A Consortium-Developed Quick Reference for Anticoagulation This toolkit was produced by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a consortium of Anticoagulation clinics and experts from across the state of Michigan. Funding for MAQI2 is provided by Blue Cross Blue Shield of Michigan and Blue Care Network through the Collaborative Quality Improvement (CQI) program. The goal of this toolkit is to provide practitioners with an up-to-date, reliable, and easy to use source of information for Anticoagulation . The content is based on the latest available evidence-based guidelines and research whenever possible. If you are aware of new guidelines or research, or if you have suggestions that can help improve this toolkit, please email us to let us know. What's new in version Added a new section for Anticoagulation in special populations, including information on AF and VTE.

Congestive heart failure 1 Hypertension 1 Age > 75 years 2 Diabetes mellitus 1 Stroke/TIA or thromboembolism (prior) 2 Vascular disease (MI, PAD, or aortic plaque) 1 Age 65-74 years 1 Sex Category (Female) 1 Total score= Score Risk AHA/ACC/HRS Guidelines1 H3 High Anticoagulate (men and women) 2 High (men) Intermediate (women) Anticoagulate (men)

Loading..

Tags:

  Earth, Failure, Congestive heart failure, Congestive, Anticoagulation

Information

Related search queries